Viewing nowYentone Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 201001640 · Notified 2010.02.23 · Insurance code 642403470
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.
Adults Administer risedronate sodium 150 mg orally once a month. Older adults No dose adjustment is necessary because the bioavailability and pharmacodynamics of this medicine in older adults (over 60 years) are similar to those in younger people. Patients with renal impairment No dose adjustment is necessary in patients with a creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Do not lie down for at least 30 minutes after taking it. If a patient forgets to take this medicine on the scheduled day, follow these instructions. If the next scheduled dose is 7 days or more away, take 1 tablet the morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. If the next scheduled dose is less than 7 days away, wait until the originally scheduled day and then take 1 tablet.
The safety and efficacy of this medicine in children under 18 years of age have not been established.
This medication may irritate the gastrointestinal mucosa, so patients with esophageal disorders, gastritis, duodenitis, ulcers, etc., should use it with caution. Take this medication with plenty of water and do not lie down for at least 30 minutes after taking it. Severe adverse reactions such as esophagitis and esophageal ulcers may rarely occur, so if symptoms such as difficulty swallowing, pain when swallowing, pain behind the sternum, or heartburn occur, stop taking the medication immediately and consult a doctor. This medication should not be administered to patients with specific esophageal disorders, hypocalcemia, pregnant women, nursing mothers, and patients with severe renal impairment. This medication contains lactose, so lactose intolerant patients should also avoid taking it. Patients allergic to any of the dyes contained in this medication should use it cautiously. Taking this medication concurrently with substances or foods containing calcium, magnesium, iron, etc., may interfere with its absorption, so take it at intervals. In rare cases, serious side effects such as jaw necrosis, atypical femoral fractures, and osteonecrosis of the outer ear may occur with long-term use, necessitating regular monitoring and management. During the use of this medication, it is important to ensure adequate intake of calcium and vitamin D, maintain weight-bearing exercises, and uphold a healthy lifestyle. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication and should consult a doctor if they are currently taking it. Safety in children has not been established, while the elderly can use it without special dosage adjustments. In cases of overdose, serum calcium and phosphorus levels may drop sharply, requiring immediate medical attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Bright blue oval film-coated tablet
1 tablet/PTP ((1 tablet/PTP)X1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 172.1mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.